Rubin Jonathan
SEC insider (Form 3/4/5 filer). CIK 0001836067. SVP, Chief Medical Officer at SUPERNUS PHARMACEUTICALS, INC. (SUPN). 40 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in ROCKVILLE, MD.
Companies Rubin Jonathan has filed insider reports for
- SUPERNUS PHARMACEUTICALS, INC. (SUPN): Officer, SVP, Chief Medical Officer
Rubin Jonathan
CIK: 0001836067
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SUPERNUS PHARMACEUTICALS, INC.
Discretionary Trading P&L
Holdings
Transaction History (40 total)
- Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
ExerciseDirect750 shares- - Aug 12, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect363 shares at avg. $46.57$17K - Jul 29, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirectPerformance Share Unit
750 shares- - Feb 25, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
DispositionDirectRestricted Stock Unit
1.3K shares- - Feb 25, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect1.3K shares- - Feb 25, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect675 shares at avg. $50.69$34K - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect603 shares at avg. $51.35$31K - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect1.1K shares- - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
AwardDirect1.3K shares- - Feb 24, 2026SUPN
SUPERNUS PHARMACEUTICALS, INC.
Tax PaymentDirect671 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Exercise | 750 | - | $0 | Direct |
| Aug 12, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 363 | $46.57 | $16,905 | Direct |
| Jul 29, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award Performance Share Unit | 750 | - | - | Direct |
| Feb 25, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Disposition Restricted Stock Unit | 1,250 | - | - | Direct |
| Feb 25, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 1,250 | - | $0 | Direct |
| Feb 25, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 675 | $50.69 | $34,216 | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 603 | $51.35 | $30,964 | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 1,125 | - | $0 | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Award | 1,250 | - | $0 | Direct |
| Feb 24, 2026 | SUPN SUPERNUS PHARMACEUTICALS, INC. | Tax Payment | 671 | - | $0 | Direct |
1-10 of 40 transactions